Nadler Financial Group Inc. Lowers Holdings in Abbott Laboratories (NYSE:ABT)
Nadler Financial Group Inc. lowered its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,174 shares of the healthcare product maker’s stock after selling 296 shares during the quarter. Nadler Financial Group […]
More Stories
CAE (NYSE:CAE) Upgraded at Desjardins
Desjardins upgraded shares of CAE (NYSE:CAE – Free Report) (TSE:CAE) from a hold rating to a buy rating in a...
Enfusion (NYSE:ENFN) Stock Price Expected to Rise, Piper Sandler Analyst Says
Enfusion (NYSE:ENFN – Free Report) had its price objective lifted by Piper Sandler from $10.00 to $11.50 in a research...
Research Analysts Set Expectations for WGO Q3 Earnings
Winnebago Industries, Inc. (NYSE:WGO – Free Report) – Research analysts at Roth Capital boosted their Q3 2025 earnings per share...
CVD Equipment (NASDAQ:CVV) Now Covered by StockNews.com
StockNews.com began coverage on shares of CVD Equipment (NASDAQ:CVV – Free Report) in a research report released on Monday. The...
Barclays Cuts Revance Therapeutics (NASDAQ:RVNC) Price Target to $3.00
Revance Therapeutics (NASDAQ:RVNC – Free Report) had its price target trimmed by Barclays from $7.00 to $3.00 in a research...
HashiCorp (NASDAQ:HCP) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of HashiCorp (NASDAQ:HCP – Free Report) in a report released on Monday morning. The firm...